336 related articles for article (PubMed ID: 24595267)
21. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
[TBL] [Abstract][Full Text] [Related]
22. iPLA2, a novel determinant in Ca2+- and phosphorylation-dependent S100A8/A9 regulated NOX2 activity.
Schenten V; Bréchard S; Plançon S; Melchior C; Frippiat JP; Tschirhart EJ
Biochim Biophys Acta; 2010 Jul; 1803(7):840-7. PubMed ID: 20219570
[TBL] [Abstract][Full Text] [Related]
23. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
24. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
25. Deficiency of S100 calcium binding protein A9 attenuates vascular dysfunction in aged mice.
Zhao B; Yu J; Luo Y; Xie M; Qu C; Shi Q; Wang X; Zhao X; Kong L; Zhao Y; Guo Y
Redox Biol; 2023 Jul; 63():102721. PubMed ID: 37163872
[TBL] [Abstract][Full Text] [Related]
26. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells.
Eue I; König S; Pior J; Sorg C
Int Immunol; 2002 Mar; 14(3):287-97. PubMed ID: 11867565
[TBL] [Abstract][Full Text] [Related]
27. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
Schiopu A; Cotoi OS
Mediators Inflamm; 2013; 2013():828354. PubMed ID: 24453429
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
[TBL] [Abstract][Full Text] [Related]
29. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
[TBL] [Abstract][Full Text] [Related]
30. S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells.
Takagi R; Sakamoto E; Kido JI; Inagaki Y; Hiroshima Y; Naruishi K; Yumoto H
Biomed Res Int; 2020; 2020():7149408. PubMed ID: 32149126
[TBL] [Abstract][Full Text] [Related]
31. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
[TBL] [Abstract][Full Text] [Related]
32. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
[TBL] [Abstract][Full Text] [Related]
33. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Sunahori K; Yamamura M; Yamana J; Takasugi K; Kawashima M; Yamamoto H; Chazin WJ; Nakatani Y; Yui S; Makino H
Arthritis Res Ther; 2006; 8(3):R69. PubMed ID: 16613612
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
35. S100A8 and S100A9 in Cancer.
Chen Y; Ouyang Y; Li Z; Wang X; Ma J
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
[TBL] [Abstract][Full Text] [Related]
36. The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
Nacken W; Kerkhoff C
FEBS Lett; 2007 Oct; 581(26):5127-30. PubMed ID: 17936757
[TBL] [Abstract][Full Text] [Related]
37. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
38. High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis.
Kabeerdoss J; Thomas M; Goel R; Mohan H; Danda S; L J; Danda D
Cytokine; 2019 Feb; 114():61-66. PubMed ID: 30594066
[TBL] [Abstract][Full Text] [Related]
39. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
40. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
